Financial Counselors Inc. increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 17.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,617 shares of the semiconductor company’s stock after purchasing an additional 4,438 shares during the quarter. Financial Counselors Inc.’s holdings in Synopsys were worth $15,504,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board boosted its holdings in Synopsys by 48.7% during the third quarter. Public Sector Pension Investment Board now owns 171,923 shares of the semiconductor company’s stock worth $87,060,000 after purchasing an additional 56,300 shares during the last quarter. Brown Shipley& Co Ltd purchased a new position in Synopsys during the third quarter worth about $3,935,000. CreativeOne Wealth LLC boosted its holdings in Synopsys by 315.1% during the third quarter. CreativeOne Wealth LLC now owns 2,250 shares of the semiconductor company’s stock worth $1,139,000 after purchasing an additional 1,708 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Synopsys by 150.8% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,434 shares of the semiconductor company’s stock worth $17,943,000 after purchasing an additional 21,304 shares during the last quarter. Finally, Blueshift Asset Management LLC purchased a new position in Synopsys during the third quarter worth about $519,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Stock Down 1.1 %
NASDAQ SNPS opened at $547.74 on Thursday. The company’s 50 day moving average is $524.12 and its 200-day moving average is $545.71. Synopsys, Inc. has a 12-month low of $457.52 and a 12-month high of $629.38. The firm has a market cap of $84.14 billion, a P/E ratio of 56.82, a price-to-earnings-growth ratio of 3.43 and a beta of 1.08.
Analyst Ratings Changes
Read Our Latest Research Report on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- NYSE Stocks Give Investors a Variety of Quality Options
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Use High Beta Stocks to Maximize Your Investing Profits
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Hang Seng index?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.